We are led by an internationally experienced executive team with a proven track record
of success in managing pharmaceutical and medical device products through multiple
regulatory, pricing and reimbursement regimes.
Currently we employ around 50 staff worldwide.
Ian, our Chairman, has over 30 years of pharmaceutical industry experience, including founding Juno Pharmaceuticals Inc. He joined Contura in 2016 as Non-Executive Chairman. Ian was previously Chief Executive of Cobalt Pharmaceuticals (2000 – 2010) and was instrumental in the development of Arrow International business units. Ian’s other past roles include Executive VP of Genpharm Inc. and senior management roles at Amerpharm/Merck Generics, a division of Merck KGaA. Ian also worked in the office of the president of Par Pharmaceuticals (US).
Rakesh has more than 25 years of experience in the pharmaceutical and medical device industry. He was appointed Contura’s Chief Executive Officer in 2021, following 12 years in previous positions of Chief Operating Officer, General Manager Northern Europe and Vice President of Marketing. Prior to his time at Contura, Rakesh spent five years at Takeda as EU Head of Specialty Products and held various roles in Corporate Development. This followed Rakesh’s earlier years at Pfizer and Pharmacia & Upjohn (1996 – 2003).
Patrick has more than 25 years of experience in the life science sector. He was Contura’s Chief Executive from 2010 to 2021, and before that he was the company’s Chief Financial Officer. Prior to joining Contura Patrick was Chief Financial Officer at Inpharmatica Limited (2001 – 2007), a chemogenomics company, and Phairson Medical Limited (1996 – 2001), a protein therapeutics discovery company. Patrick is a Chartered Accountant by training and prior to his career in the life science sector he worked for 10 years in the financial markets practice of Arthur Andersen in London.
Graham brings more than 20 years of pharmaceutical industry experience to the company. He joined Contura in 2016 as a Non-Executive Director. Graham is Chief Executive of Aspire Pharma Limited, which he established in 2009. Aspire specialises in the licensing and marketing of both branded and generic medicines. Prior to establishing Aspire, Graham held sales and marketing roles with GSK and Dominion Pharma, and was Managing Director of Pliva Pharma UK.
Craig has over 15 years of pharmaceutical industry experience. Prior to co-founding Juno in 2011, Craig worked for Cobalt Pharmaceuticals in its business development group. He was responsible for negotiating product license and supply agreements for Cobalt’s OTC and generic divisions, and was Cobalt’s primary lead on all global M&A transactions.